Home
Concomitant splenic artery ligation has no preventive effect on left-sided portal hypertension following pancreaticoduodenectomy with the resection of the portal and superior mesenteric vein confluence for pancreatic ductal adenocarcinoma

Concomitant splenic artery ligation has no preventive effect on left-sided portal hypertension following pancreaticoduodenectomy with the resection of the portal and superior mesenteric vein confluence for pancreatic ductal adenocarcinoma

Acest material este disponibil doar utilizatorilor înregistrați în platformă. Vă rugăm să vă logați sau să solicitați un cont de utilizator pentru a avea acces la conținutul științific.

Oana Isache

Asociația Română de Chirurgie Hepato-Bilio-Pancreatică și Transplant Hepatic

Despre
Noutăți
GDPR

Link-uri utile

Cursuri
Cum funcționează
Solicită cont

Contact

0722 904 715
IC Fundeni; Șos.Fundeni 258, București
contact@chirurgiehbp.ro

Concomitant splenic artery ligation has no preventive effect on left-sided portal hypertension following pancreaticoduodenectomy with the resection of the portal and superior mesenteric vein confluence for pancreatic ductal adenocarcinoma

Concomitant splenic artery ligation has no preventive effect on left-sided portal hypertension following pancreaticoduodenectomy with the resection of the portal and superior mesenteric vein confluence for pancreatic ductal adenocarcinoma

Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma

A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial

Asociația Română de Chirurgie Hepato-Bilio-Pancreatică și Transplant Hepatic

Link-uri utile

Contact

Concomitant splenic artery ligation has no preventive effect on left-sided portal hypertension following pancreaticoduodenectomy with the resection of the portal and superior mesenteric vein confluence for pancreatic ductal adenocarcinoma

Performance of non-invasive biomarkers compared with invasive methods for risk prediction of posthepatectomy liver failure in hepatocellular carcinoma

A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial

You may also like

35th IASGO World Congress in Cairo

Simpozion ARCHBPTH, IASGO la Congresul Național de Chirurgie din 14 iunie 2024

Simpozion ARCHBPTH, IASGO la Congresul Național de Chirurgie, 14 iunie 2024

Asociația Română de Chirurgie Hepato-Bilio-Pancreatică și Transplant Hepatic​

Link-uri utile

Contact

Asociația Română de Chirurgie Hepato-Bilio-Pancreatică și Transplant Hepatic